NIVENS, Michael Chadham,BOUYSSOU, Thierry,GOEGGEL, Rolf,SEITHER, Peter
申请号：
LT13713199
公开号：
LT2833884T
申请日:
2013.04.02
申请国别(地区):
LT
年份:
2020
代理人:
摘要：
The present invention relates to CCR3 inhibitors of formula 1, wherein R1 is H, C1-6-alkyl, C0-4-alkyl-C3-6-cycloalkyl, C1-6-haloalkyl； R2 is H, C1-6-alkyl； X is an anion selected from the group consisting of chloride or ½ dibenzoyltartrate j is 1 or 2. for use as a medicament for the treatment of diseases selected from dry age-related macular degeneration (dAMD), wet age-related macular degeneration (wAMD), retinopathy of prematurity (ROP), central retinal vein occlusion (CRVO), nasal polyposis, eosinophilic esophagitis, eosinophillic gastroenteritis (e.g. eosinophilic gastritis and eosinophilic ententeritis), hypereosinophilic syndrome and Churg Strauss syndrome.
